BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22296363)

  • 1. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies.
    Wu K; Su D; Lin K; Luo J; Au WW
    Asian Pac J Cancer Prev; 2011; 12(9):2237-43. PubMed ID: 22296363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XRCC1 Arg399Gln polymorphism is not associated with breast cancer in Chinese.
    Guo S; Mao X; Ming L
    Int J Clin Exp Med; 2015; 8(7):10429-36. PubMed ID: 26379833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis.
    Liu DY; Liang HC; Xiao XM
    Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis.
    Wei X; Chen D; Lv T
    Mol Biol Rep; 2013 Jan; 40(1):567-72. PubMed ID: 23096083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.
    Wu D; Jiang H; Gu Q; Zhang D; Li Z
    Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis.
    Huang Y; Li L; Yu L
    Mutagenesis; 2009 Jul; 24(4):331-9. PubMed ID: 19465687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
    Saadat M; Ansari-Lari M
    Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
    Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
    Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women.
    Malisic EJ; Krivokuca AM; Boljevic IZ; Jankovic RN
    Cancer Biomark; 2015; 15(5):685-91. PubMed ID: 26406958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
    Liu B; Shen T
    Tumour Biol; 2014 Jan; 35(1):507-12. PubMed ID: 24052436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies.
    Liu C; Yin Q; Jiao G; Zhou X; Ying M; Gao W; Hu J; Wei L; Wang N; Wang Y
    DNA Cell Biol; 2014 Jun; 33(6):378-87. PubMed ID: 24694255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between X-ray repair cross-complementation group 1 rs25487 polymorphism and pancreatic cancer risk.
    Jiang H; Wu D; Ma D; Lin G; Liang J; Jin J
    Tumour Biol; 2013 Dec; 34(6):3417-21. PubMed ID: 23807675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis.
    Liu BM; Liu TM; You BS; You HY; Yang J; Li L; He YC
    Genet Mol Res; 2012 Nov; 11(4):3852-60. PubMed ID: 23212324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of the Arg399Gln polymorphisms of the XRCC1 gene with breast cancer risk in Kyrgiz women].
    Isakova ZhT; Makieva KB; E T Talaibekova ; Asambaeva DA; Sultangazieva BB; Aldashev AA
    Vopr Onkol; 2015; 61(6):941-4. PubMed ID: 26995983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese.
    Li Y; Huang Y; Cao YS; Zeng J; Tong WN; Xu SL; Zhuo AS
    Tumour Biol; 2013 Dec; 34(6):3681-5. PubMed ID: 23884604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the Link between XRCC1 Arg399Gln Polymorphism and Breast Cancer: a Meta-Analysis in a Single Ethnic Group.
    Chen XP; Wen HF; Zhang F; Xu WH; Ma ZC; Fu SM
    Clin Lab; 2017 Apr; 63(4):725-731. PubMed ID: 28397459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: a meta-analysis.
    Chi XX; Liu YY; Shi SN; Cong Z; Liang YQ; Zhang HJ
    Mol Vis; 2015; 21():335-46. PubMed ID: 25873778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XRCC1 Arg399Gln polymorphism and bladder cancer risk: updated meta-analyses based on 5767 cases and 6919 controls.
    Zhuo W; Zhang L; Cai L; Zhu B; Chen Z
    Exp Biol Med (Maywood); 2013 Jan; 238(1):66-76. PubMed ID: 23479765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.